ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2023

Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial.

Vimal K Derebail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.